SUN PHARMA ADVANCED RESEARCH COMPANY
Back to Cashflow Statement
|
SUN PHARMA ADVANCED RESEARCH COMPANY Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | |
|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹-0.89 Cr | ₹-3.38 Cr | ₹4.74 Cr | ₹-0.64 Cr |
What is the latest Net Cash Inflow / Outflow ratio of SUN PHARMA ADVANCED RESEARCH COMPANY ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2026 | ₹-0.89 Cr |
| Mar2025 | ₹-3.38 Cr |
| Mar2024 | ₹4.74 Cr |
| Mar2023 | ₹-0.64 Cr |
How is Net Cash Inflow / Outflow of SUN PHARMA ADVANCED RESEARCH COMPANY Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2026 | ₹-0.89 Cr | Negative | |
| Mar2025 | ₹-3.38 Cr | Negative | |
| Mar2024 | ₹4.74 Cr | Positive | |
| Mar2023 | ₹-0.64 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of SUN PHARMA ADVANCED RESEARCH COMPANY
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUN PHARMA ADVANCED RESEARCH COMPANY | ₹6,019.5 Cr | -7.6% | -6% | 30.8% | Stock Analytics | |
| PRIME FOCUS | ₹24,983.1 Cr | 1.3% | 20.7% | 68.3% | Stock Analytics | |
| SAGILITY | ₹21,023.8 Cr | -0.3% | 5.9% | 3.1% | Stock Analytics | |
| SYNGENE INTERNATIONAL | ₹15,345.5 Cr | -1.6% | -5.7% | -42.1% | Stock Analytics | |
| INDEGENE | ₹13,806.2 Cr | -2.3% | 1.9% | 2.5% | Stock Analytics | |
| INTERNATIONAL GEMOLOGICAL INSTITUTE | ₹13,589.3 Cr | 1% | -11.5% | -16.2% | Stock Analytics | |
SUN PHARMA ADVANCED RESEARCH COMPANY Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUN PHARMA ADVANCED RESEARCH COMPANY | -7.6% |
-6% |
30.8% |
| SENSEX | -1.6% |
-4.7% |
-8.3% |
You may also like the below Video Courses